P. Parsons

发表

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.

D. Fairlie, C. Hansen, P. Parsons, 1997, Biochemical pharmacology.

The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells

S. Pavey, P. Parsons, Sharon Mason, 2010, Investigational New Drugs.

EBC-232 and 323: A Structural Conundrum Necessitating Unification of Five In Silico Prediction and Elucidation Methods.

P. Parsons, Carly J. Pierce, G. Boyle, 2020, Chemistry.

Characterization of the Melanoma miRNAome by Deep Sequencing

N. Hayward, M. Stark, D. Whiteman, 2010, PloS one.

Multimodal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo.

Idriss Blakey, Kristofer J Thurecht, Cameron Alexander, 2014, Journal of the American Chemical Society.

In vitro sensitivity of ovarian cancer as determined by a short-term biochemical assay: comparison between primary and metastatic sites in the same patient.

M. J. Webb, P. Parsons, E. Mackay, 1989, Gynecologic oncology.

Synthetic Tigliane Intermediates Engage Thiols to Induce Potent Cell Line Selective Anti-Cancer Activity.

P. Parsons, G. Boyle, Mingzhao Zhu, 2020, Chemistry.

Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells

P. Parsons, R. Sturm, J. Pedley, 2005, Peptides.

A melanoma octamer binding protein is responsive to differentiating agents.

P. Parsons, R. Sturm, H. Takahashi, 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Induction of metallothionein in human skin by routine exposure to sunlight: evidence for a systemic response and enhanced induction at certain body sites.

D. Whiteman, P. Parsons, E. Ablett, 2003, The Journal of investigative dermatology.

Alpha B‐Crystallin, a New Independent Marker for Poor Prognosis in Head and Neck Cancer

P. Parsons, J. Pedley, G. Boyle, 2005, The Laryngoscope.

p53 expression and risk factors for cutaneous melanoma: A case‐control study

D. Whiteman, P. Parsons, A. Green, 1998, International journal of cancer.

Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy.

J. Dickinson, P. Parsons, Y. Dong, 1997, Biochemical pharmacology.

Histone Hyperacetylation Induced by Histone Deacetylase Inhibitors Is Not Sufficient to Cause Growth Inhibition in Human Dermal Fibroblasts*

P. Parsons, B. Gabrielli, A. Burgess, 2001, The Journal of Biological Chemistry.

Anticancer agents from the Australian tropical rainforest: Spiroacetals EBC-23, 24, 25, 72, 73, 75 and 76.

P. Parsons, V. Gordon, P. Reddell, 2009, Chemistry.

Inhibition of melanization in human melanoma cells by a serotonin uptake inhibitor.

P. Parsons, M. McEwan, 1987, The Journal of investigative dermatology.

Melphalan‐induced chromosome damage in sensitive and resistant human melanoma cell lines

P. Parsons, L. Morrison, 1978, International journal of cancer.

A TaqI RFLP of the human TGFα gene is significantly associated with cutaneous malignant melanoma

N. Hayward, P. Parsons, K. Ellem, 1988, International journal of cancer.

INHIBITION OF DNA REPAIR SYNTHESIS BY SUNLIGHT

P. Parsons, I. Hayward, I. P. Hayward, 1985, Photochemistry and photobiology.

Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.

P. Parsons, J. Pedley, S. Cozzi, 2006, Cancer research.

Pathway Hyperactivation of the Mitogen-Activated Protein Kinase Dependent − Melanoma Cells via Protein Kinase C Treated − Induction of Senescence in Diterpene Ester

P. Parsons, J. Pedley, S. Cozzi, 2006 .

What is transforming growth factor-beta (TGF-β)?

P. Parsons, G. Boyle, W. Coman, 2004 .

Cyclophosphamide resistance developed in a human melanoma cell line.

P. Parsons, M. Boon, 1984, Cancer treatment reports.

Novel organometallic cationic ruthenium(II) pentamethylcyclopentadienyl benzenesulfonamide complexes targeted to inhibit carbonic anhydrase

C. Supuran, A. Innocenti, D. Vullo, 2009, JBIC Journal of Biological Inorganic Chemistry.

A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy

G. Dranoff, A. Kelso, S. Burrows, 1997, Cancer Immunology, Immunotherapy.

Ploidy of Surgically Treated Primary Lung-Cancer

P. Zimmerman, P. Parsons, M. Bint, 1987 .

Ectopic expression of protein kinase C-β sensitizes head and neck squamous cell carcinoma to diterpene esters.

R. Adams, P. Parsons, Carly J. Pierce, 2015, Anticancer research.

H‐Cadherin expression reduces invasion of malignant melanoma

A. Bosserhoff, N. Hayward, V. Bonazzi, 2009, Pigment cell & melanoma research.

Potent Antibacterial Prenylated Acetophenones from the Australian Endemic Plant Acronychia crassipetala

P. Parsons, S. Ogbourne, P. Reddell, 2020, Antibiotics.

Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.

P. Parsons, E. Kable, D. Favier, 1989, Cancer research.

' s response to reviews Title : Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer

P. Parsons, 2022 .

Improved β-galactosidase reporter assays: optimization for low activity in mammalian cells

P. Parsons, R. Sturm, E. Ablett, 1998 .

UVB-specific regulation of gene expression in human melanocytic cells: cell cycle effects and implication in the generation of melanoma.

P. Parsons, R. Sturm, J. Pedley, 1998, Mutation research.

POTENCY AND SELECTIVE TOXICITY OF TETRA(HYDROXYPHENYL)‐ AND TETRAKIS(DIHYDROXYPHENYL)PORPHYRINS IN HUMAN MELANOMA CELLS, WITH AND WITHOUT EXPOSURE TO RED LIGHT

P. Parsons, D. Arnold, D. A. James, 1994, Photochemistry and photobiology.

Inhibition of melanin synthesis by cystamine in human melanoma cells.

B. Gardiner, P. Parsons, R. Sturm, 2000, The Journal of investigative dermatology.

Determination of proliferating fractions in malignant melanomas by anti‐PCNA/cyclin monoclonal antibody

P. Parsons, H. Takahashi, G. Strutton, 1991, Histopathology.

EBC-219: a new diterpene skeleton, crotinsulidane, from the Australian rainforest containing a bridgehead double bond.

P. Parsons, Carly J. Pierce, A. I. Savchenko, 2014, Angewandte Chemie.

Modification of dopa toxicity in human tumour cells.

P. Parsons, 1985, Biochemical pharmacology.

Expression of α2-macroglobulin receptor/low density lipoprotein receptor-related protein on surfaces of tumour ceils: a study using flow cytometry

Yonghe Li, P. Parsons, D. Yellowlees, 1997 .

Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.

S. Pavey, E. Musgrove, P. Parsons, 2001, Molecular pharmacology.

CDKN2A/p16 is inactivated in most melanoma cell lines.

P. Pollock, N. Hayward, P. Parsons, 1997, Cancer research.

What is transforming growth factor-beta (TGF-beta)?

P. Parsons, G. Boyle, W. Coman, 2004, British journal of plastic surgery.

Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies.

Wei Chen, P. Parsons, R. Sturm, 2003, Pigment cell research.

Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity.

G. Eaglesham, P. Parsons, J. Bartley, 1997, Biochemistry.

Reduced αB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma

P. Parsons, G. Boyle, B. Panizza, 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Relationships between thermotolerance, oxidative stress responses and induction of stress proteins in human tumour cell lines.

P. Parsons, K. Watson, E. Steels, 1992, Biochemical pharmacology.

Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction

P. Parsons, R. Sturm, A. Smith, 1998, Melanoma research.

Genotoxicity and cell cycle effects of platinum-based imaging agents in cisplatin-resistant human tumour cells

S. Khoo, P. Parsons, S. Khoo, 1990, Cancer Chemotherapy and Pharmacology.

Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines.

P. Parsons, T. Hurst, E. Kable, 1990, Biochemical pharmacology.

Effects of adriamycin and etoposide on the replication of adenovirus 5 in sensitive and resistant human tumour cells.

P. Parsons, S. Khoo, J. Lark, 1989, Biochemical pharmacology.

Mechanism of melphalan resistance developed in vitro in human melanoma cells.

L. Morrison, P. Parsons, Regius Mary Sister, 1981, Cancer research.

Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas.

P. Parsons, T. Hurst, S. Khoo, 1992, International journal of cell cloning.

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.

P. Pollock, N. Hayward, P. Parsons, 1995, Oncogene.

Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.

P. Parsons, I. Hayward, 1986, Biochemical pharmacology.

Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia.

P. Parsons, M. Lavin, G. Birrell, 1998, British Journal of Cancer.

Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.

P. Parsons, I. Hayward, 1984, Cancer research.

Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models

R. Adams, P. Parsons, Carly J. Pierce, 2014, PloS one.

Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate1

D. Kavanagh, J. Lord, P. Parsons, 2006, The Journal of Immunology.

Antiproliferative and depigmenting effects of the histamine (H2) agonist dimaprit and its derivatives on human melanoma cells.

P. Parsons, G. Fechner, H. Takahashi, 1992, Biochemical pharmacology.

In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression.

P. Parsons, H. Takahashi, 1990, Pigment cell research.

Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds

P. Parsons, M. Gumbleton, Carly J. Pierce, 2022, Science Translational Medicine.

The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines.

P. Parsons, P. Goss, 1977, Cancer research.

Solar and UVC-induced mutation in human cells and inhibition by deoxynucleosides.

D. Moss, P. Parsons, J. Staples, 1989, Mutation research.

RESISTANCE OF PIGMENTED HUMAN CELLS TO KILLING BY SUNLIGHT AND OXYGEN RADICALS

P. Parsons, P. Musk, 1987, Photochemistry and photobiology.

In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts.

P. Parsons, R. Sturm, J. Thomson, 1993, Pigment cell research.

Complete removal of mycoplasma from viral preparations using solvent extraction.

P. Parsons, A. Suhrbier, A. Bellett, 1995, Journal of virological methods.

Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family.

P. Parsons, R. Sturm, I. S. Dunn, 1995, Genomics.

The in vitro cytotoxicity and DNA alkylating ability of the simplest functional analogues of the seco CC-1065 alkylating subunit

P. Parsons, D. Young, R. H. White, 1995 .

Adenovirus replication as an in vitro probe for drug sensitivity in human tumors.

P. Parsons, J. Little, G. Mcleod, 1986, European journal of cancer & clinical oncology.

Can skin cancer in humans be prevented by alleviation of oxidative stress?

P. Parsons, 1997, Redox report : communications in free radical research.

A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease.

P. Parsons, B. Gabrielli, T. Sculley, 2002, Transplantation.

Localization of the gene for human proliferating nuclear antigen/cyclin by in situ hybridization

G. Chenevix-Trench, P. Parsons, G. Webb, 1990, Human Genetics.

Detection of the c‐met proto‐oncogene product in normal skin and tumours of melanocytic origin

P. Parsons, Hiroyuki Takahashi, N. Sawada, 1994, The Journal of pathology.

Surfactant protein expression in human skin: evidence and implications.

P. Parsons, G. Boyle, M. Roberts, 2007, The Journal of investigative dermatology.

Reduction of DNA synthesis, pigment synthesis, pigmentation gene mRNA and resistance to UVB in human melanoma cells treated with analogues of a histamine (H2) agonist.

P. Parsons, R. Sturm, G. Fechner, 1994, Biochemical pharmacology.

Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma

F. Speleman, J. Vandesompele, P. Parsons, 2004, Oncogene.

Inhibition of retinoblastoma protein translation by UVB in human melanocytic cells and reduced cell cycle arrest following repeated irradiation.

P. Parsons, R. Sturm, I. S. Dunn, 1996, Oncogene.

Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis

M. Waters, P. Parsons, B. Conway-Campbell, 2007, Proceedings of the National Academy of Sciences.

Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.

S. Burrows, D. Moss, P. Parsons, 1989, Pigment cell research.

J. Clements, P. Parsons, G. Boyle, 2010 .

Calcium concentration defines two stages in transformation of lymphocytes by epstein‐barr virus

S. Burrows, D. Moss, P. Parsons, 1984, International journal of cancer.

Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions.

N. Hayward, P. Parsons, J. Palmer, 1994, Oncogene.

Cockayne syndrome associated with low CSF 5-hydroxyindole acetic acid levels

V. Fung, P. Parsons, K. North, 2000, Journal of medical genetics.

The Aromatic Head Group of Spider Toxin Polyamines Influences Toxicity to Cancer Cells

A. Loukas, Jennifer J. Smith, P. Parsons, 2017, Toxins.

Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells

P. Parsons, E. Kable, 2004, Cancer Chemotherapy and Pharmacology.

Potency, selectivity and cell cycle dependence of catechols in human tumour cells in vitro.

P. Parsons, E. Kable, 1988, Biochemical pharmacology.

DNA Damage and Selective Toxicity of Dopa and Ascorbate : Copper in Human Melanoma Cells 1

L. Morrison, P. Parsons, 2006 .

DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.

L. Morrison, P. Parsons, 1982, Cancer research.

Croton insularis introduces the seco-casbane class with EBC-329 and the first casbane endoperoxide EBC-324.

P. Parsons, Carly J. Pierce, A. I. Savchenko, 2014, Chemical communications.

Heteroatom‐Interchanged Isomers of Lissoclinamide 5: Copper(II) Complexation, Halide Binding, and Biological Activity

P. Comba, P. Parsons, D. Watters, 2018 .

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

P. Parsons, A. Suhrbier, S. Cozzi, 2004, Cancer research.

Histopathology of melanocytic lesions in goats and establishment of a melanoma cell line: a potential model for human melanoma.

P. Parsons, J. Candy, H. Takahashi, 1990, Pigment cell research.

[4+2] cycloaddition reactions between 1,8-disubstituted cyclooctatetraenes and diazo dienophiles: stereoelectronic effects, anticancer properties and application to the synthesis of 7,8-substituted bicyclo[4.2.0]octa-2,4-dienes.

P. Parsons, V. Gordon, P. Reddell, 2010, Chemistry.

Rhodium-Catalyzed [4+3] Cycloaddition to Furans: Direct Access to Functionalized Bicyclo[5.3.0]decane Derivatives

P. Parsons, G. Boyle, S. Chow, 2016 .

Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere.

David A Winkler, John Tsanaktsidis, B. A. Chalmers, 2016, Angewandte Chemie.

Selective toxicity of deoxyadenosine analogues in human melanoma cell lines.

P. Parsons, Raymond L. Blakley, E. Bowman, 1986, Biochemical pharmacology.

Synthesis, structure and cytotoxicity studies of four-coordinate bis (cis-bis(diphenylphosphino)ethene) gold(I) complexes, [Au(dppey)(2)]X.

P. Parsons, P. Healy, M. Williams, 2010, Journal of inorganic biochemistry.

Selective, cytotoxic organoruthenium(II) full-sandwich complexes: a structural, computational and in vitro biological study.

Christopher L. Brown, B. Cunning, P. Parsons, 2012, Chemistry, an Asian journal.

Synthesis, structure, and selective cytotoxicity of organometallic Cp*RuII O-alkyl-N-phenylcarbamate sandwich complexes

P. Parsons, P. Healy, T. Carruthers, 2010 .

Seco-cyclopentane glucosides from Menyanthes trifoliata: foliamenthin, dihydrofoliamenthin, and menthiafolin

P. Parsons, A. Battersby, A. R. Burnett, 1968 .

Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-).

P. Parsons, P. Healy, M. Williams, 2008, Inorganic chemistry.

Cell Cycle Delay, Mitochondrial Stress and Uptake of Hydrophobic Cations Induced by Sunscreens in Cultured Human Cells

P. Parsons, Chunxia Xu, 1999, Photochemistry and photobiology.

The in vitro Antitumour Activity of Substituted Dibutyl-1,3,2-dioxastannolanes

P. Parsons, S. Ng, D. Young, 1997 .

Mono- and 1,1′-Disubstituted Organoruthenium Cyclopentadiene Complexes: Synthesis, Structural Characterization, and Antitumoral Evaluation

P. Parsons, P. Healy, B. T. Loughrey, 2011 .

Critical targets of protein kinase C in differentiation of tumour cells.

P. Parsons, D. Watters, 1999, Biochemical pharmacology.

Epigenetic effects of the methylating agent 5-(3-methyl-1-triazeno) imidazole-4-carboxamide in human melanoma cells.

P. Parsons, I. Hayward, 1984, The Australian journal of experimental biology and medical science.

Expression of p53 tumor suppressor protein in sun-exposed skin and associations with sunscreen use and time spent outdoors: a community-based study.

D. Whiteman, P. Parsons, A. Green, 2006, American journal of epidemiology.

Photosensitization of the Sunscreen Octyl p‐Dimethylaminobenzoate by UVA in Human Melanocytes but not in Keratinocytes ¶

A. Parisi, P. Parsons, Chunxiao Xu, 2001 .

Photosensitization of the Sunscreen Octyl p-Dimethylaminobenzoate by UVA in Human Melanocytes but not in Keratinocytes¶

A. Parisi, P. Parsons, A. Green, 2001, Photochemistry and Photobiology.

Steroidal saponins from the roots of Smilax sp.: Structure and bioactivity

P. Parsons, J. J. Voss, Victoria L. Challinor, 2012, Steroids.

Cytotoxicity studies of human melanoma cells and fibroblasts.

P. Parsons, S. G. Brown, 1979, The Australian journal of experimental biology and medical science.

Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity.

P. Parsons, J. Pedley, G. Boyle, 2009, The Journal of investigative dermatology.

Regulation of tyrosinase expression and activity in human melanoma cells via histamine receptors.

P. Parsons, M. McEwan, 1991, The Journal of investigative dermatology.

Structure and bioactivity of steroidal saponins isolated from the roots of Chamaelirium luteum (false unicorn).

W. Kitching, P. Parsons, L. Lambert, 2012, Journal of natural products.

Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid.

D. Fairlie, P. Parsons, G. Boyle, 2006, Journal of medicinal chemistry.

Furofuran lignans from the Simpson Desert species Eremophila macdonnellii.

P. Parsons, G. Boyle, A. I. Savchenko, 2017, Fitoterapia.

Characterization of a novel monoclonal antibody, 3H‐1, reactive with squamoproliferative lesions and squamous‐cell cancers

D. Moss, P. Parsons, J. Kearsley, 1991, International journal of cancer.

The First Plant 5,6-Secosteroid from the Australian Arid Zone Species Frankenia foliosa

P. Parsons, G. Boyle, A. I. Savchenko, 2017 .

Prognostic significance of monoclonal antibody 3H‐1 reactivity with squamous‐cell head‐and‐neck cancers

D. Moss, D. Battistutta, P. Parsons, 1991, International journal of cancer.

Synthesis and spectroscopic characterisation of a combinatorial library based on the fungal natural product 3‐chloro‐4‐hydroxyphenylacetamide

P. Parsons, G. Pierens, Rohan A. Davis, 2007, Magnetic resonance in chemistry : MRC.

Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands

P. Parsons, X-m Zhang, G. Gros, 1994, Melanoma research.

Dimaprit analogues inhibit tyrosinase via a disulphide breakdown product independently of the histamine H2 receptor.

P. Parsons, G. Fechner, J. Jacobs, 1994, Biochemical and biophysical research communications.

The First Casbane Hydroperoxides EBC-304 and EBC-320 from the Australian Rainforest.

P. Parsons, Carly J. Pierce, A. I. Savchenko, 2017, Chemistry.

Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process

P. Parsons, Jacinta L. Simmons, Carly J. Pierce, 2016, Scientific Reports.

Topical treatments for skin cancer.

P. Parsons, Jacinta L. Simmons, G. Boyle, 2019, Advanced drug delivery reviews.

Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma.

D. Duffy, Wei Chen, L. Griffiths, 2001, The Journal of investigative dermatology.

Head and neck cancer: past, present and future

P. Parsons, G. Boyle, S. Porceddu, 2006, Expert review of anticancer therapy.

Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas

P. Parsons, H. Takahashi, M. Yamamoto, 1996, Histopathology.

Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells.

P. Parsons, H. Takahashi, 1992, The Journal of investigative dermatology.

Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours

P. Parsons, Hiroyuki Takahashi, H. Kishi, 2004, Virchows Archiv.

Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers.

C. Potten, P. Parsons, O. Nikaido, 1998, The Journal of investigative dermatology.

Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.

D. Moss, P. Parsons, M. McEwan, 1988, The Journal of investigative dermatology.

Human malignant melanoma cell lines.

J. H. Pope, D J Moss, L. Morrison, 1979, Pathology.

Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4‐S‐cysteaminylphenol binds protein disulphide isomerase

S. Ito, P. Parsons, K. Jimbow, 1991, Melanoma research.

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

D. Fairlie, C. Hansen, P. Parsons, 1999, British Journal of Cancer.

Neutron irradiation of human melanoma cells.

P. Parsons, K. Brown, M. Ichihashi, 1989, Pigment cell research.

Alteration of Melanoma Melanogenesis by Phenotypic Modifiers

K. Wakamatsu, S. Ito, P. Parsons, 1992, The Journal of dermatology.

Determinants of melanocyte density in adult human skin

D. Whiteman, P. Parsons, A. Green, 1999, Archives of Dermatological Research.

Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes

P. Parsons, Jacinta L. Simmons, G. Boyle, 2021, Scientific reports.

Properties of human melanoma cells resistant to 5-(3',3'-dimethyl-1-triazeno)imidazole-4-carboxamide and other methylating agents.

L. Morrison, P. Parsons, I. Hayward, 1982, Cancer research.

Expression studies of pigmentation and POU-domain genes in human melanoma cells.

P. Parsons, R. Sturm, J. Pedley, 1994, Pigment cell research.

Inhibition of melanogenesis in human melanoma cells by novel analogues of the partial histamine (H2) agonist nordimaprit.

P. Parsons, G. Fechner, J. Jacobs, 1993, Biochemical pharmacology.

Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumours

P. Parsons, Hiroyuki Takahashi, K. Jimbow, 2005, Virchows Archiv A.

Stimulation of melanogenesis in a human melanoma cell line by bistratene A.

P. Parsons, D. Watters, B. Garrone, 1998, Biochemical pharmacology.

PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.

P. Parsons, R. Sturm, G. Muscat, 2009, The international journal of biochemistry & cell biology.

Solid phase immunoassay for high molecular weight alkaline phosphatase in human sera using a specific monoclonal antibody.

P. Parsons, J. T. Deng, J. Deng, 1988, Clinica chimica acta; international journal of clinical chemistry.

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

M. Cummings, P. Parsons, M. McGuckin, 1997, The Journal of pathology.

Differential effects of NAD, nicotinamide and related compounds upon growth and nucleoside incorporation in human cells.

P. Parsons, I. Hayward, 1983, Biochemical pharmacology.

Temperature‐sensitive DNA repair of ultraviolet damage in human cell lines

P. Parsons, P. Goss, 1976, International journal of cancer.

Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate

P. Parsons, G. Boyle, B. Panizza, 2019, Investigational New Drugs.

PLOIDY AS A PROGNOSTIC DETERMINANT IN SURGICALLY TREATED LUNG CANCER

P. Zimmerman, G. Hawson, P. Parsons, 1987, The Lancet.

TOXICITY, DNA DAMAGE AND INHIBITION OF DNA REPAIR SYNTHESIS IN HUMAN MELANOMA CELLS BY CONCENTRATED SUNLIGHT

P. Parsons, P. Musk, 1982, Photochemistry and photobiology.

Detection in human melanoma cell lines of particles with some properties in common with RNA tumour viruses

J. H. Pope, P. Parsons, P. Goss, 1974, International journal of cancer.

Sensitivity of human neuroblastoma to activated dacarbazine: relationships between cell survival, methyltransferase activity and activation of adenovirus-5.

P. Parsons, P. Smith, M. Lihou, 1988, European journal of cancer & clinical oncology.

Isolation and confirmation of the proposed cleistanthol biogentic link from Croton insularis.

P. Parsons, Carly J. Pierce, Lidia A. Maslovskaya, 2011, Organic letters.

Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.

P. Parsons, K. Maynard, 1986, Cancer research.

DNA DAMAGE AND REPAIR IN HUMAN CELLS EXPOSED TO SUNLIGHT

P. Parsons, P. Goss, 1980, Photochemistry and photobiology.

Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.

G. Margison, P. Parsons, T. Cerny, 1989, Cancer research.

EBC-342: A Novel Tetrahydrofuran Moiety Containing Casbane from the Australian Rainforest

P. Parsons, Carly J. Pierce, G. Boyle, 2020 .

New Halimanes from the Australian Rainforest Plant Croton Insularis

P. Parsons, Carly J. Pierce, G. Boyle, 2019, European Journal of Organic Chemistry.

New Casbanes and the First trans-Cyclopropane seco-Casbane from the Australian Rainforest Plant Croton insularis.

P. Parsons, Carly J. Pierce, G. Boyle, 2019, Chemistry.

EBC-318 and 339: bicyclo[10.2.1]alkanes from Croton insularis

P. Parsons, Carly J. Pierce, Lidia A. Maslovskaya, 2016 .

seco‐Casbanes from the Australian Rainforest: ECD Predictions Key for Determining Remote Absolute Configuration

P. Parsons, Carly J. Pierce, Lidia A. Maslovskaya, 2016 .

EBC-316, 325–327, and 345: New Pimarane Diterpenes from Croton insularis Found in the Australian Rainforest

P. Parsons, Carly J. Pierce, Lidia A. Maslovskaya, 2015 .

Unprecedented 1,14-seco-crotofolanes from Croton insularis: oxidative cleavage of crotofolin C by a putative homo-Baeyer-Villiger rearrangement.

P. Parsons, Carly J. Pierce, A. I. Savchenko, 2014, Chemistry.

Alkaloid biosynthesis. Part XV. Partial synthesis and isolation of vincoside and isovincoside: biosynthesis of the three major classes of indole alkaloids from vincoside

P. Parsons, A. Battersby, A. R. Burnett, 1969 .

Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.

P. Parsons, R. Sturm, G. Muscat, 2000, European journal of biochemistry.

Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.

P. Parsons, G. Boyle, W. Coman, 2004, British journal of plastic surgery.

Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.

D. Fairlie, P. Parsons, A. Saul, 2000, International journal for parasitology.

Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma

N. Hayward, P. Parsons, J. Palmer, 1994, International journal of cancer.

Increased expression of cyclin‐dependent kinase inhibitor 2 (CDKN2A) gene product P16 INK4A in ovarian cancer is associated with progression and unfavourable prognosis

M. Cummings, P. Parsons, M. McGuckin, 1997, International journal of cancer.

BRN2 in melanocytic cell development, differentiation, and transformation

P. Parsons, R. Sturm, G. Boyle, 2006 .

TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma

P. Parsons, K. Ellem, N. Hayward, 1989, Human Genetics.

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Markus Ringnér, Pamela M Pollock, Peter Hersey, 2004, Oncogene.

Effects of calcium depletion on human cells in vitro and the anomalous behavior of the human melanoma cell line MM170.

P. Parsons, J. Leah, P. Goss, 1983, Cancer research.

Selective proliferation of human tumour cells in calcium-depleted medium.

P. Parsons, 1978, The Australian journal of experimental biology and medical science.

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer

M. Cummings, P. Parsons, G. Boyle, 2006, International journal of cancer.

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

M. Cummings, P. Parsons, B. Gabrielli, 1997, International journal of cancer.

Anomalous Behavior of the Human Melanoma Cell Line MM 170 and the in Vitro Effects of Calcium Depletion on Human Cells

P. Parsons, J. Leah, P. Goss, 2006 .

Decreased calcium dependence of lymphoblastoid cell lines compared with burkitt lymphoma cell lines

D. Moss, P. Parsons, K. Maynard, 1985, International journal of cancer.

Melanoma Cell Lines Adenovirus 5 and Herpes Simplex Virus Type 1 in Human Alkyltransferase Activity , and Reactivation of Methylated-Alkylguanine-DNA 6 O Relationships among Cell Survival

G. Margison, P. Parsons, T. Cerny, 2006 .

Search for human tumour viruses by transfection: uptake of melanoma and Epstein-Barr virus DNA by human cells.

J. H. Pope, P. Parsons, S. G. Brown, 1979, The Australian journal of experimental biology and medical science.

Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms

P. Parsons, G. Boyle, Guangbiao Zhou, 2012, Cancer and Metastasis Reviews.

Oncornavirus‐like particles in malignant melanoma and control biopsies

J. H. Pope, P. Parsons, N. Davis, 1976, International journal of cancer.

Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

D. Fairlie, P. Parsons, B. Gabrielli, 2000, Molecular biology of the cell.

Cisplatin Chemotherapy of Ovarian Cancer: Is Short‐Term In Vitro Chemosensitivity Predictive of Long‐Term Patient Survival?

M. J. Webb, P. Parsons, J. Kearsley, 1988, The Australian & New Zealand journal of obstetrics & gynaecology.

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell‐mediated immune recognition of human melanoma cells

R. Tampé, P. van Endert, L. Cooper, 1998, International journal of cancer.

The human genome and gene expression profiling.

P. Parsons, G. Boyle, W. Coman, 2006, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment

J. Clements, P. Parsons, Jonathan M. Harris, 2013, PloS one.

Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer

P. Parsons, A. Green, G. Boyle, 2009, BMC Cancer.

Histone deacetylase inhibitors and malignant melanoma.

P. Parsons, G. Boyle, A. Martyn, 2005, Pigment cell research.

Measurement of tumor cell activity in short‐term primary culture. Clinical significance in women with ovarian cancer

M. J. Webb, P. Parsons, J. Kearsley, 1988, Cancer.

Biphasic Response of the Metallothionein Promoter to Ultraviolet Radiation in Human Melanoma Cells

D. Fairlie, P. Parsons, M. West, 1997, Photochemistry and photobiology.

Influence of ageing, heat shock treatment and in vivo total antioxidant status on gene-expression profile and protein synthesis in human peripheral lymphocytes

P. Parsons, G. Boyle, D. Rao, 2003, Mechanisms of Ageing and Development.

Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer.

M. J. Webb, P. Parsons, J. Kearsley, 1988, Gynecologic oncology.

The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.

P. Parsons, M. Roberts, B. Smithers, 1997, British Journal of Cancer.

Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma

P. Parsons, M. Roberts, B. Smithers, 1994, Melanoma research.

Isolated limb perfusion with melphalan for human melanoma xenografts in the hindlimb of nude rats: a surviving animal model

P. Parsons, B. Smithers, M. Roberts, 1997, Melanoma research.

Adriamycin-induced DNA Adducts Inhibit the DNA Interactions of Transcription Factors and RNA Polymerase (*)

P. Parsons, R. Sturm, S. Cutts, 1996, The Journal of Biological Chemistry.

Clinical value of in vitro drug sensitivity testing based on short‐term effects on dna and rna metabolism in ovarian cancer

M. J. Webb, P. Parsons, J. Kearsley, 1989, Journal of surgical oncology.

A gel mobility shift assay for probing the effect of drug-DNA adducts on DNA-binding proteins.

P. Parsons, R. Sturm, S. Cutts, 1997, Methods in molecular biology.

Neural cell adhesion molecule expression: No correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck

P. Parsons, G. Boyle, B. Panizza, 2009, Head & neck.

Novel markers for poor prognosis in head and neck cancer

P. Parsons, J. Pedley, G. Boyle, 2005, International journal of cancer.

Survey of human lymphoblastoid cell lines and primary cultures of normal and leukaemic leukocytes for oncornavirus production

P. Parsons, E. Klucis, Leanne Jackson, 1976, International journal of cancer.

The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.

G. Sutherland, P. Parsons, R. Sturm, 1995, Oncogene.

Biomarkers for Cancers of the Head and Neck

D. Moss, P. Parsons, G. Boyle, 2008 .

The effect of drugs on the cell cycle of Giardia intestinalis

P. Parsons, G. Hoyne, P. Boreham, 1989, Parasitology.

Serum Omega-3 and Omega-6 Fatty Acids and Cutaneous p53 Expression in an Australian Population

P. Parsons, A. Green, G. Boyle, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.

P. Parsons, 1984, Cancer research.

Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

G. Chenevix-Trench, M. Friedlander, R. Kefford, 1992, Oncogene.

Up-regulation of growth hormone receptor immunoreactivity in human melanoma.

M. Waters, P. Parsons, F. Sinowatz, 1999, Anticancer research.

The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate.

P. Parsons, S. Ogbourne, 2014, Fitoterapia.

Chromosome damage and DNA repair induced in human fibroblasts by UV and cholesterol oxide.

P. Parsons, P. Goss, 1978, The Australian journal of experimental biology and medical science.

PCNA immunostaining in breast cancer.

M. Cummings, P. Parsons, C. Furnival, 1993, The Australian and New Zealand journal of surgery.

Purine deoxynucleoside metabolism in human melanoma cells with a high spontaneous mutation rate.

R. Christopherson, S. Rose, P. Parsons, 1996, Mutation research.

Isoflavonoid photoprotection in mouse and human skin is dependent on metallothionein.

D. Whiteman, P. Parsons, J. Pedley, 2006, The Journal of investigative dermatology.

Transcriptional responses of human melanocytes to solar UV.

P. Parsons, J. Pedley, G. Boyle, 1999, Redox report : communications in free radical research.

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

Andrew W Boyd, Sabe Sabesan, M. Cummings, 2006, BMC Cancer.

Daniela Loessner, Judith A Clements, J. Clements, 2010, Cancer research.

Alkaloid biosynthesis. Part XIV. Secologanin: its conversion into ipecoside and its role as biological precursor of the indole alkaloids

P. Parsons, A. Battersby, A. R. Burnett, 1969 .

Proceedings of the First International Conference on PEP005

J. Lord, P. Parsons, A. Suhrbier, 2007, Anti-cancer drugs.

A rapid method for determining recent sunscreen use in field studies.

D. Whiteman, P. Parsons, Chunxiao Xu, 2003, Journal of photochemistry and photobiology. B, Biology.

A nonconsensus octamer‐recognition sequence (TAATGARAT‐motif) identifies a novel DNA binding protein in human merkel cell carcinoma cell lines

P. Parsons, R. Sturm, J. Leonard, 1994, International journal of cancer.

Gene Expression Profiling Reveals Two Distinct Subtypes of Merkel Cell Carcinoma

F. Speleman, P. Parsons, A. Paepe, 2003 .

Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines.

P. Parsons, A. Stowers, P. Musk, 1990, Biochemical pharmacology.

Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.

R. Ruddon, P. Parsons, W. C. Dermody, 1984, Cancer treatment reports.

A Comparison of the Potent in vitro Antitumor Activity of Triphenyltin Benzoates with that of Related Tin Compounds

P. Parsons, D. Young, C. Tranter, 1995 .

Top-Accessed Article: UV Light Tanning as a Type of Substance-Related Disorder

P. Parsons, H. Takahashi, F. Sinowatz, 2016 .

Expression of p 53 Tumor Suppressor Protein in Sun-exposed Skin and Associations with Sunscreen Use and Time Spent Outdoors : A Community-based Study

D. Whiteman, P. Parsons, A. Green, 2006 .

The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers

P. Parsons, A. Suhrbier, S. Cozzi, 2011, The British journal of dermatology.

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

M. Cummings, P. Parsons, M. McGuckin, 1997, The Journal of pathology.

The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants.

D. Battistutta, P. Parsons, A. Green, 1994, Controlled clinical trials.

The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate.

P. Parsons, S. Ogbourne, 2014, Fitoterapia.

Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.

D. Fairlie, P. Parsons, G. Boyle, 2004, Journal of Medicinal Chemistry.